Abbott Laboratories
Connections
Quotes
As we've seen from Abbott Labs and Covidien, when you take a company like this and break it up into a medical products business and a drug business, it creates a tremendous amount of value. I see no reason why Baxter should be any different
We’re extremely proud of our outcomes in 2012 ... From the expansion of Abbott Labs to the growth at Caresource and Midmark, the Dayton Region performed well.
In the past week, medical testing companies, such as Quest Diagnostics, medical device makers Johnson & Johnson and Abbott Laboratories, hospital operators, such as HCA Holdings Inc., and even diaper maker Kimberly-Clark, which has a surgical supply unit, have cited a slowdown in use of medical services.More quotes »
Around the web
-
Gabelli Starts Abbott Labs (ABT) at Buy
a Buy. PT $47.00. For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here. Shares of Abbott Labs closed at $37.81 yesterday, with a 52 week range of $31.91-$72.47. Join StreetInsider.com 9:03 AM from Street Insider Read more »
-
July Options Now Available For Abbott Laboratories (ABT)
at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Abbott Laboratories, and highlighting in green where the $36.00 strike is located relative to that history: Turning to the calls side from Forbes Blogs Read more »
-
Stock Upgrades And Downgrades: ABT, KMX, JCP, LOW, P, PCLN, RHT, SNDK
Balachander) A number of stocks were upgraded and downgraded by Wall Street analysts on Monday. Abbott Laboratories (NYSE: ABT) upgraded to "Buy" from "Neutral" at Goldman Sachs. Shares rose 2.05 percent to trade at $37.35. Accenture Plc (NYSE: ACN) upgraded from iStockAnalyst Read more »
-
Benzinga's Top Upgrades
have an account? Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday. Deutsche Bank upgraded priceline.com from Benzinga.com Read more »
-
Abbott Laboratories lifted to buy at Goldman Sachs
to see how this story relates to your portfolio? Just add items to create a portfolio now: MADRID (MarketWatch) -- Abbott Laboratories (NYSE:ABT) was upgraded to buy from neutral by Goldman Sachs, which also lifted its 12-month price target to $44 from $38 from MarketWatch Read more »
